SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37618
Submission : 2023-03-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33205
Submission : 2018-10-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11051
Submission : 1994-08-01
Status : Active
Type : IV
NDC Package Code : 50516-001
Start Marketing Date : 2014-05-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 1996-030 - Rev 04
Issue Date : 2015-12-21
Type : Chemical
Substance Number : 178
Status : Valid
Registration Number : 222MF10150
Registrant's Address : La Haute Loge LESTREM FRANCE
Initial Date of Registration : 2010-05-17
Latest Date of Registration :
NDC Package Code : 52647-001
Start Marketing Date : 2014-06-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 40087-1001
Start Marketing Date : 2022-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69507-001
Start Marketing Date : 2015-01-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11051
Submission : 1994-08-01
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37618
Submission : 2023-03-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33205
Submission : 2018-10-11
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : IBUPROFEN
Dosage Form : TABLET; ORAL
Application Number : 79129
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : IBUPROFEN
Dosage Form : TABLET; ORAL
Application Number : 79174
Country : US
Patented : No
Drug : CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 78252
Country : US
Patented : No
Drug : CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 65430
Country : US
Patented : No
Drug : HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 18814
Country : US
Patented : No
Drug : HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 18814
Country : US
Patented : No
Drug : CIPROFLOXACIN
Dosage Form : INJECTABLE; INJECTION
Application Number : 78062
Country : US
Patented : No
Drug : CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 78024
Country : US
Patented : No
Drug : AZACTAM IN PLASTIC CONTAINER
Dosage Form : INJECTABLE; INJECTION
Application Number : 50632
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Listed Dossiers
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5.05
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : NASAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5.5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : NASAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : ORAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 46.2
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Fillers Diluents Binders
Parenteral
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
MARKET PLACE
